Morales, Anecita .
HRN: 29-11-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2026
06/19/2026
IV
500mg
Q8h
Spontaneous Bacterial Peritonitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines